Autonomix shares positive data from transvascular RF ablation trial [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
transvascular radiofrequency (RF) ablation use in managing pain associated with pancreatic cancer. Out of the first five subjects evaluated in the trial, 60% responded with a mean 6.33 reduction of pain on the visual analogue scale pain scale at seven days post-procedure. All members of the responder group had clinically meaningful pain relief at seven days post-procedure. Responder patients reported a mean 78% improvement in quality of health and a mean 45% improvement in quality of life after seven days. The first five patients have been treated for procedural familiarity but will be excluded from the study's objective analysis. Autonomix said the trial will enrol 20 subjects at a single clinical site, with the primary goal of the study to successfully target and ablate the nerves responsible for pain in pancreatic cancer patients using RF ablation via a transvascular method. The company's catheter-based technology is designed to detect neural signals linked to pain or disease
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- HAE vs. BSX: Which Stock Is the Better Value Option? [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE™ Pulsed Field Ablation SystemPR Newswire
- Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- 4 Medical Product Stocks to Buy From a Prospective Industry [Yahoo! Finance]Yahoo! Finance
- Impulse Dynamics Expands Executive Leadership Team [Financial Post (Toronto, Ontario, Canada)]Financial Post
BSX
Earnings
- 7/24/24 - Beat
BSX
Sec Filings
- 9/6/24 - Form 4
- 9/5/24 - Form 144
- 9/3/24 - Form 4
- BSX's page on the SEC website